Nishant C Saxena, Chief Business Officer at Corbus Pharmaceuticals, bought CRBP on Aug 11, 2026
Data as of Oct 16
▲ BUY$25K2,600 shares at $9.63Nishant C Saxena Chief Business OfficerCRBP Corbus Pharmaceuticals Holdings, Inc.
- Traded
- Aug 11, 2026
- Disclosed
- Aug 12, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CRBP since disclosure
−53.7%
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Aug 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.